Moderna requests vaccine go ahead after ‘highly efficacious’ data

About This Source - Al Jazeera English

The video item below is a piece of English language content from Al Jazeera. Al Jazeera is a Qatari state-funded broadcaster based in Doha, Qatar, owned by the Al Jazeera Media Network.

Recent from Al Jazeera English:

  • Are the measures against COVID-19 failing? | Inside Story
  • French ski resorts suffer losses as COVID rules hit winter sports
  • More than 200 detained over farmers’ protests in New Delhi
  • Al Jazeera English published this video item, entitled “Moderna requests vaccine go ahead after ‘highly efficacious’ data” – below is their description.

    US drugmaker Moderna has applied for emergency clearance from the US and European regulators for its vaccine.

    Moderna is just a week behind Pfizer, which applied for emergency approval on November 20.

    Moderna says its final trial results confirm it is more than 94 percent effective.

    The Trump administration reiterated that distribution would begin shortly after the expected approvals of the Moderna and Pfizer shots.

    Al Jazeera’s Gabriel Elizondo reports from New York, the US.

    Al Jazeera English YouTube Channel

    Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

    In This Story: Donald Trump

    Donald John Trump is the 45th and current president of the United States. Before entering politics, he was a businessman and television personality. Trump was born and raised in Queens, a borough of New York City, and received a bachelor’s degree in economics from the Wharton School.

    5 Recent Items: Donald Trump

  • Biden Team Is ‘Monitoring’ the Surge in GameStop Shares, Psaki Says
  • John Kerry Says U.S. Will Work With China on Climate Change Despite Conflicts
  • Putin Warns of Global Tensions Similar to 1930s in Davos Speech
  • Antony Blinken Sworn In as Secretary of State by Kamala Harris
  • YouTube extends Trump’s ban indefinitely
  • In This Story: Moderna

    Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

    CEO: Stéphane Bancel (2011–)

    Stock ticker: (NASDAQ:MRNA)

    5 Recent Items: Moderna

  • Biden Promises 200 Million More Vaccine Doses, Faster Rollout: World Brief
  • Coronavirus: BC couple gains notoriety for allegedly jumping vaccine queue
  • Biden announces purchase of more doses of Pfizer, Moderna vaccines
  • Race to get the vaccine like ‘Hunger Games’ due to limited supply
  • Biden administration plans to buy 200M more Covid-19 vaccine doses
  • In This Story: Pfizer

    Pfizer Inc. (NYSE: PFE) is an American multinational pharmaceutical corporation headquartered in New York City. In 2012, it was one of the world’s largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

    5 Recent Items: Pfizer

  • Coronavirus: US to squeeze more vaccine doses out of Pfizer’s vials using special syringes
  • EU urges vaccine makers to ‘honour obligations’ amid supply fears
  • Biden Promises 200 Million More Vaccine Doses, Faster Rollout: World Brief
  • French firm Sanofi to help produce 100 million doses of Pfizer Covid-19 vaccine
  • Biden announces purchase of more doses of Pfizer, Moderna vaccines
  • Leave a Comment